Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mabgène

1997 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Producer of antibodies and related glycoprotein in animal cell-based systems. The company specializes in the production of recombinant proteins and monoclonal antibodies from expression based on mammalian cell systems.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
LFB Group
Primary Office
  • Impasse des Chenes Rouges
  • 30319 Alès
  • France

Mabgène Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Mabgène‘s full profile, request access.

Request full access to PitchBook

Mabgène Executive Team (1)

Name Title Board
Seat
Contact
Info
Patrick Henno Founder & Chief Executive Officer